Canadian nuclear operator Bruce Power announced the world’s first production of lutetium-177 (Lu-177) at a commercial nuclear reactor, its Bruce-7 nuclear power plant in Ontario.
The Canadian company said it has partnered on the project with two other companies – Isogen, a joint venture between Kinectrics and Framatome, and ITM Isotope Technologies Munich – to produce the short-lived radioisotope.
The Canadian company said it has partnered on the project with two other companies – Isogen, a joint venture between Kinectrics and Framatome, and ITM Isotope Technologies Munich – to produce the short-lived radioisotope.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
